The ever-changing microenvironment of Staphylococcus aureus in cutaneous infections

Abstract

Background: Staphylococcus aureus is responsible for the majority of skin and soft tissue infections, which are often diagnosed at a late stage, thereby impacting treatment efficacy. Our study was designed to reveal the physiological changes at different stages of infection by S. aureus through the combined analysis of variations in the skin microenvironment, providing insights for the diagnosis and treatment of S. aureus infections.

Methods: We established a murine model of skin and soft tissue infection with S. aureus as the infectious agent to investigate the differences in the microenvironment at different stages of infection. By combining analysis of the host immune status and histological observations, we elucidate the progression of S. aureus infection in mice.

Results: The results indicate that the infection process in mice can be divided into at least two stages: early infection (1–3 days post-infection) and late infection (5–7 days post-infection). During the early stage of infection, notable symptoms such as erythema and abundant exudate at the infection site were observed. Histological examination revealed infiltration of numerous neutrophils and bacterial clusters, accompanied by elevated levels of cytokines (IL-6, IL-10). There was a decrease in microbial alpha diversity within the microenvironment (Shannon, Faith’s PD, Chao1, Observed species, Simpson, Pielou’s E). In contrast, during the late stage of infection, a reduction or even absence of exudate was observed at the infected site, accompanied by the formation of scabs. Additionally, there was evidence of fibroblast proliferation and neovascularization. The levels of cytokines and microbial composition gradually returned to a healthy state.

Conclusion: This study reveals synchrony between microbial composition and histological/immunological changes during S. aureus-induced SSTIs.

Keywords

microbial composition / skin and soft tissue infection / Staphylococcus aureus

References

[1] Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751-762.

[2] Mempel M, Voelcker V, Köllisch G, et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003;121:1389-1396.

[3] Kebaier C, Chamberland RR, Allen IC, et al. Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis. 2012;205:807-817.

[4] Widaa A, Claro T, Foster TJ, O’Brien FJ, Kerrigan SW. Staphylococcus aureus protein a plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS ONE. 2012;7:e40586.

[5] Grundmann H, Aires-De-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874-885.

[6] Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13:252.

[7] Linz MS, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics (Basel). 2023;12(3):557.

[8] Shopsin B, Kreiswirth BN. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2001;7:323-326.

[9] Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8:137.

[10] Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin Infect Dis. 2019;68:S193-S199.

[11] Huo W, Busch LM, Hernandez-Bird J, et al. Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice. Nat Microbiol. 2022;7:796-809.

[12] Liang J, Zou G, Chiming G, et al. Study on skin infection model of Staphylococcus aureus based on analytic hierarchy process and Delphi method. Heliyon. 2023;9(6):e16327.

[13] National Toxicology Program. NTP toxicology and carcinogenesis studies of pyridine (CAS No. 110-86-1) in F344/N rats, Wistar rats, and B6C3F1 mice (drinking water studies). National Toxicology Program Technical Report Series; 2000:470.

[14] Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998–2004). Diagn Microbiol Infect Dis. 2007;57:7-13.

[15] Stieferman AE, Mazi P, Burnham JP. Severe skin and soft-tissue infections. Semin Respir Crit Care Med. 2022;43(1):3-9.

[16] Matsumoto M, Nakagawa S, Zhang L, et al. Interaction between staphylococcus Agr virulence and neutrophils regulates pathogen expansion in the skin. Cell Host Microbe. 2021;29:930-940.e4.

[17] Ridder MJ, McReynolds AKG, Dai H, Pritchard MT, Markiewicz MA, Bose JL. Kinetic characterization of the immune response to methicillin resistant Staphylococcus aureus subcutaneous skin infection. Infect Immun. 2022;90(7):1-16.

[18] Zapf RL, Wiemels RE, Keogh RA, et al. The small RNA Teg41 regulates expression of the alpha phenol-soluble modulins and is required for virulence in Staphylococcus aureus. MBio. 2019;10:e02484-18.

[19] Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219-229.

[20] Nurden AT. The biology of the platelet with special reference to inflammation, wound healing and immunity. Front Biosci (Landmark Ed). 2018;23:726-751.

[21] Darby IA, Laverdet B, Bonte F, Desmouliere A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014;7:301-311.

[22] Li K, Qiu H, Yan J, et al. The involvement of TNF-α and TNF-β as proinflammatory cytokines in lymphocyte-mediated adaptive immunity of Nile tilapia by initiating apoptosis. Dev Comp Immunol. 2021;115:103884.

[23] Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and ageing. Immunology. 2020;160(2):116-125.

[24] Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244-253.

[25] Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324:1190-1192.

[26] Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694-1697.

[27] Borkowski AW, Gallo RL. The coordinated response of the physical and antimicrobial peptide barriers of the skin. J Invest Dermatol. 2011;131:285-287.

[28] Lai Y, Cogen AL, Radek KA, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defence against bacterial skin infections. J Invest Dermatol. 2010;130:2211-2221.

[29] Meisel JS, Sfyroera G, Bartow-McKenney C, et al. Commensal microbiota modulate gene expression in the skin. Microbiome. 2018;6:20.

[30] Kong HH, Andersson B, Clavel T, et al. Performing skin microbiome research: a method to the madness. J Investigative Dermatol. 2017;137:561-568.

[31] O’Sullivan JN, Rea MC, O’Connor PM, Hill C, Ross RP. Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens. FEMS Microbiol Ecol. 2019;95(2):fiy241.

[32] Gaitanis G, Tsiouri G, Spyridonos P, et al. Variation of cultured skin microbiota in mothers and their infants during the first year postpartum. Pediatric Dermatol. 2019;36(4):460-465.

[33] Coates M, Lee MJ, Norton D, MacLeod AS. The skin and intestinal microbiota and their specific innate immune systems. Front Immunol. 2019;10:2950.

[34] Nakatsuji T, Chen TH, Butcher AM, et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv. 2018;4(2):eaao4502.

[35] Linehan JL, Harrison OJ, Han S-J. et al. Non-classical immunity controls microbiota impact on skin immunity and tissue repair. Cell. 2018;172:784-796.

[36] Zhang M, Jiang Z, Li D, et al. Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing. Microb Ecol. 2015;69:415-421.

RIGHTS & PERMISSIONS

2024 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.